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a b s t r a c t
Increasing integration of computed tomography (CT) into routine patient care has escalated concerns
regarding associated radiation exposure. Specific patient cohorts, particularly those with cystic fibrosis
(CF) and Crohn's disease, have repeat exposures and thus have an increased risk of high lifetime cu-
mulative effective dose exposures.
Thoracic CT is the gold standard imaging method in the diagnosis, assessment and management of
pulmonary disease. In the setting of CF, CT demonstrates increased sensitivity compared with pulmonary
function tests and chest radiography. Furthermore, in specific cases of Crohn's disease, CT demonstrates
diagnostic superiority over magnetic resonance imaging (MRI) for radiological evaluation.
Low dose CT protocols have proven beneficial in the evaluation of CF, Crohn's disease and renal calculi,
and in the follow up of testicular cancer patients. For individuals with chronic conditions warranting
frequent radiological follow up, the focus must continue to be the incorporation of appropriate CT use
into patient care. This is of particular importance for the paediatric population who are most susceptible
to potential radiation induced malignancy.
CT technological developments continue to focus on radiation dose optimisation. This article aims to
highlight these advancements, which prioritise the acquisition of diagnostically satisfactory images with
the least amount of radiation possible.
© 2020 The Authors. Published by Elsevier Ltd on behalf of The College of Radiographers. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction
A significant and widespread increase in the utilisation of
computed tomography (CT) has been evident in recent decades. In
2017, in excess of 6 million CT examinations were conducted across
UK hospitals.1
Concerns regarding CT associated radiation exposure are
heightening; compared with conventional diagnostic radiographs,
CT results in exposure to much higher radiation doses. A routine
thoracic CT can potentially deliver an effective dose that is 50-fold
higher than that associated with a standard chest radiograph.2
Additionally, the potential inherent radiation dose associated
with CT has increased as faster image acquisition speeds facilitate
vascular and multi-phase examinations. Consequently, it can be
surmised that the increased reliance on CT imaging has resulted in
a concomitant rise in medical exposure to ionising radiation in the
population.3 Concurrent with the increasing use of CT, advances in
CT technology have facilitated significant reductions in radiation
exposure during individual examinations. Dose optimisation aims
to produce a diagnostically satisfactory image while keeping the
radiation dose as low as reasonably achievable.
This review article provides a brief overview of patient cohorts
at heightened risk of excessive radiation exposures. Additionally,
various CT dose reduction strategies applicable to these specific
groups will be discussed, highlighting the potential clinical benefits
of implementing such strategies, based on experience at our centre
over the past decade.
Concerns regarding an increasing reliance on CT imaging
Invaluable in the diagnosis of complex medical issues, CT is
widely accepted as one of the more momentous recent advances in
medicine, with integration into routine patient care responsible for
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improved patient outcomes. Whilst CT use in the emergency
department setting has risen across the United States (US),4 this has
been disproportionate to the increase in patient attendances at
emergency departments.5 Furthermore, a corresponding variation
in diagnostic yield has not been demonstrated. Increasing avail-
ability of CT resources may be contributing to a supply-induced
demand, resulting in increased utilisation of CT, without a
demonstrable increase in quality of patient care.
CT remains the largest contributor to medical radiation expo-
sure, accounting for almost 50% of the collective effective dose. This
is concerning; as a stochastic process, the probability of radiation
induced carcinogenesis increases with escalating radiation dose
exposures. Compared with adults, children are much more sus-
ceptible to these stochastic effects; their tissues demonstrate
increased radiosensitivity due to rapid cell division and growth.
Health information
Quantification of medical radiation associated risk is difficult;
several clinical studies have attempted quantification of risk of
malignancy from CT radiation exposure.6,7 However, precise
calculation of both the probability of harm and potential severity of
that harm is almost impossible. Available data regarding radiation
induced malignancy is population based as opposed to individual
calculated risk. Given the latency of radiation induced cancer is
10e20 years, effects of radiation exposure may not become
apparent for decades, if at all.
Whilst published estimates of radiation exposure associated
cancer risk include the induction of 125 breast cancers per 100,000
women screened between ages 40 and 74 years,8 and a 1.8% in-
crease in lung cancer incidence if 50% of the population between
the ages of 50 and 75 years were screened annually with CT for lung
cancer, estimation of diagnostic range ionizing radiation exposure
associated risk remains controversial.9
The United Nations Scientific Committee on the Effects of
Atomic Radiation (UNSCEAR) has reported uncertainty in relation
to the health effects of low dose radiation. At doses less than
100 mSv, the risk of radiation induced malignancy is thought to be
too small to be distinguishable from other risk factors for cancer
development.10,11 However, a retrospective cohort study, evaluating
the risk of leukaemia and brain tumours associated with CT im-
aging performed in paediatric patients, noted that in the 10 years
following first CT scan undertaken in patients younger than 10
years, one excess case of leukaemia and one excess case of a brain
tumour per 10,000 head CT scans occurred.6 Recently, flow
cytometry techniques have facilitated assessment of biomarkers of
radiation damage at diagnostic levels as low as 7.5 mSv.12 This data
verifies that damage is occurring, and being repaired, in most
individuals. However, it also demonstrates that individuals with
damage or mutation to their repair pathways do not repair the
damage caused by low dose radiation. This reinforces the need for
radiation doses to be “personalised” or appropriate to the individ-
ual, rather than the average patient.
Reports projecting cancer risk associated with ever increasing
CT use have resulted in a heightened awareness among patients
regarding potential adverse health outcomes secondary to ionizing
radiation exposure. This is compounded by the relatively high
volume of inaccurate information, related to CTassociated radiation
exposure, to be found on Internet searches; an assessment of
Internet searches for details regarding radiation safety noted that
information provided on webpages is accurate in just two thirds of
cases.13
Cohorts with potential for excessive radiation exposures
Approximately 50% of total population radiation dose exposure
is now accounted for by medical imaging14; CT is responsible for
approximately 60% of total dose exposure associated with medical
imaging.15 Cumulative effective dose (CED), a measure of the total
radiation dose incurred by a patient over time secondary to
repeated exposures during diagnostic imaging, is of particular
concern among younger patient cohorts; associated risks are
deemed higher once CT is performed on younger patients.
Specific patient cohorts are acknowledged as being at increased
risk for high lifetime CED. These include patients with testicular
cancer,16 cystic fibrosis (CF),17 inflammatory bowel disease (in
particular Crohn's disease (CD) patients),18 lymphoma19 and end-
stage kidney disease,20 in addition to trauma patients, and pa-
tients admitted within intensive care facilities for extended periods
of time.21
Of heightened significance is that age at the time of first radia-
tion exposure is now accepted as an independent risk factor for
subsequent cancer mortality. For patients with CF and CD, this is of
particular relevance as first clinical presentation typically occurs
within the paediatric setting.
CF patients have CEDs in excess of the general population, with a
6-fold increase in the use of CT scanning for these patients re-
ported.17 These individuals will proceed to an average of 3.2
thoracic CT scans (range 0e13) during their lifetime.22 Mean annual
effective dose for a cohort of paediatric patients with CF has been
recorded as 0.15mSv/year; CED between birth and 18 years of age is
estimated at 3.5 mSv.23 Furthermore, average age at first CT Thorax
has reduced significantly in recent years, from 20 years for patients
born pre 1980, to 1.9 years for patients born post 1997.22 In view of
their multisystem disorder, abdominal imaging contributes to a
significant proportion of total CED exposure for CF patients; in
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excess of 40% of all radiologic imaging may be directed at the
abdominopelvic region.17 Traditionally, diagnostic abdominal CT
imaging necessitates much higher radiation doses compared with
the thoracic equivalent.
Consequently, patients with inflammatory bowel disease, in
particular CD, are also at increased risk of exposure to high levels of
radiation associated with their diagnostic imaging studies. High
levels of both annual CED and total CED are independently asso-
ciated with CD, with values of >9.6 mSv/annum and >30.8 mSv,
respectively.24 Most CD patients receive their diagnosis between
the ages of 15 and 40 years, with one large US epidemiological
study reporting a median age at diagnosis of 29.5 years.25 This
young age profile at diagnosis, in addition to, often, decades of
active disease mean CD patients frequently proceed to repeated
abdominal imaging. CD patients with penetrating and upper
gastrointestinal tract disease, along with those warranting treat-
ment with intravenous steroids and biologics, all have associated
increased CEDs.18
Testicular cancer is themost common cancer affectingmen aged
between 14 and 44 years26; CT, endorsed by standard international
protocols, is essential in staging and surveillance. However, CT ac-
counts for up to 98.3% of CED amongst this patient group, with a
median CED of 125.1 mSv reported.16
CT dose optimisation strategies
In general terms, when selecting a radiological investigation or
procedure, the consequent radiation exposure must always be
considered. As highlighted in the “Image wisely” and “Image
gently” campaigns,27,28 a three-tiered approach to radiation pro-
tection is beneficial:
 the as low as reasonably achievable (ALARA) principle;
 justification of the imaging procedure;
 dose limitation.
Essentially, the optimal method for reducing radiation dose is to
avoid unwarranted CT imaging, and instead utilise alternative im-
aging modalities in an effort to limit, or even eliminate, radiation
exposure. With particular relevance to the paediatric population,
this may be aided by the provision of imaging consultations to
advise referring physicians on the most appropriate diagnostic
imaging pathway.29
CT associated patient radiation exposure is estimated using 3
main metrics: volume CT dose index (CTDI)vol represents the ra-
diation dose output from the scanner; dose-length product (DLP)
represents the radiation dose over the total scan; and effective dose
(ED) measures the equivalent whole-body dose which would have
the same risk of the biologic effect. ED, expressed as the millisievert
(mSv), is formulated by the summation of absorbed doses to indi-
vidual organs weighted for their radiation sensitivity.
In cases where CT is deemed necessary on clinical grounds, it
must be considered that CT associated radiation dose is dependent
on a number of scanning parameters including: tube current, tube
voltage, scanning length, table pitch, gantry rotation time, colli-
mation, table speed and shielding (Table 1).
Image noise, a significant predictor of image quality, is inversely
related to X-ray beam energy; though radiation dose can be
reduced directly through alterations to tube current and tube
voltage, this impacts negatively on image noise. Tube current
reduction is the most accessible method of reducing CT radiation
dose, though this process again increases image noise. Potentially, a
50% reduction in radiation dose exposure can be achieved through
a 50% reduction in tube current.30 Additionally, tube voltage affects
both image noise and tissue contrast by virtue of the quantity of
radiation administered; radiation output is proportional to the
square of tube voltage. Consequently, even minimal decreases in
tube voltage can aid significant dose reduction.31 When imaging
paediatric patients, it is important that weight-based protocols are
followed; smaller patients may necessitate a proportional increase
in tube current to balance their relative inherent lack of soft-tissue
contrast.
Radiation dose exposure and image noise are further affected by
patient positioning relative to the isocenter. Optimisation of image
quality and radiation dose may be achieved in part by patient
positioning at the isocenter of the CT gantry. As the complexity of
CT examinations increases, so too does the potential for centering
error; isocenter misalignment is greater during CT colonography
compared with abdominopelvic CT (CT-AP) or CT kidneys, ureters,
bladder (CT-KUB).32
Patient centering within the CT scanner is classically achieved
through manual adjustment of both the patient and table position
by the radiographer, with the assistance of laser guides. However,
in spite of these laser beams facilitating visual assessment of the
central positioning of patients, the technique does demonstrate
variability between users; patient positioning at a non-ideal table
height is not infrequent. As a means of improving table height se-
lection, body contour detection has gained notable support in
recent times; 3D cameras for body contour detection have been
demonstrated to improve the accuracy of patient positioning
compared with manual positioning.33
CT filters aim to reduce those soft X-rays which do not
contribute to development of a diagnostic image, in spite of
constituting a degree of absorbed ionising radiation.34 Bowtie fil-
ters, a type of CT filter, harden the X-ray beam by removal of those
low energy X-rays. They further concentrate the X-rays in the
central aspect of the scanned anatomy, resulting in increased image
quality and a reduction in surface dose of 50% when comparedwith
flat filters. Given the elliptical body shape of most paediatric pa-
tients, these Bowtie filters offer significant dose reduction potential
for the paediatric population.
Furthermore, the use of shielding during CT examinations has
gained support as a means of dose reduction. Particularly targeted
at protecting superficial organs, shielding materials such as lead
and bismuth potentially attenuate the primary X-ray beam by up to
50% and 60% for the eye lens and breast, respectively.35 The
shielding of radiation transmission requires balance; the reduction
of direct radiation exposure to the thyroid, eyes, gonads and breast
tissue must not compromise the generation of diagnostically
satisfactory images.
Advances in CT technologies aimed at dose optimisation
Developments in CT technology are focused on reducing radia-
tion exposure as low as reasonably achievable, whilst maintaining
diagnostic yield; recent advances have yielded significant re-
ductions in radiation dose exposure in many clinical settings.
Though any reduction in CT radiation dose is to be encouraged,
limitations include increased image noise with secondary reduced
image quality. This must be compensated for, if a detrimental effect
on image quality, resulting in a non-diagnostic imaging study, is to
be avoided.
Automatic tube current modulation (ATCM), a type of automatic
exposure control (AEC), works on the basis that pixel noise on CT
scanning is attributable to quantum (random) noise in the image
projections. ATCM aims tomaintain constant CT image quality, with
a reduced radiation dose exposure, through automatic tube current
adjustment in various planes according to the size and attenuation
of the imaged body area. Whilst maintaining image quality, ATCM
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has facilitated dose reductions of 31% and 21% for arterial and portal
phase CT imaging of the abdomen, respectively.36
As a dose reduction strategy, adaptive section collimation offers
significant potential for very young children. Most effective in scan
ranges less than 12 cm, it reduces radiation exposure due to over-
scanning; dose savings of up to 38% have been reported.37
Although bismuth shielding offers a mechanism for dose
reduction to specific radiosensitive organs included in the field of
view, organ-based dose modulation systems offer further potential
to reduce the radiation exposure to superficially located organs. The
technique exposes centrally located viscera to a constant radiation
dose, thereby maintaining image quality, while those organs sited
superficially are subject to a reduced radiation exposure within the
prescribed 120 radial arc. Utilisation of an organ-based dose
modulation system (liver dose right index) has demonstrated a
statistically signficant reduction in radiation dose exposure to the
breast and pelvic area, compared with standard AEC.38
Whilst standard CT scanners reconstruct images using filtered
back projection (FBP), algorithms utilising iterative reconstruction
(IR) have been produced to reconstruct image data using a system
of models to improve image noise. IR isolates noise from CT images
obtained at reduced exposure, maintaining image quality and
interpretability, thus producing considerable radiation dose
reduction whilst preserving satisfactory image quality, when
compared with traditional FBP.
IR techniques significantly decrease subjective and quantitative
image noise on both standard and reduced dose thoracic CT. Dose
reductions of up to 63.8% for thoracic CT in paediatric patients can
be achieved using adaptive statistical iterative reconstruction
(ASIR) (GE Healthcare, MI, USA), without significantly compro-
mising image quality.39
More advanced forms of IR include model-based iterative
reconstruction (MBIR), a type of “pure” IR. Pure IR results in high
quality images, with potential for dose reductions in excess of
80%.40 MBIR facilitates ultra-low dose thoracic imaging, with
maintenance of image quality, at doses approaching that of a chest
radiograph.41,42
CT dose optimisation research strategies: effects on radiation
exposure
Our centre has developed various low dose CT research pro-
tocols for use when imaging individuals from the above mentioned
patient cohorts. Furthermore, for select groups, namely patients
with CF, these low dose protocols have now been adopted into
routine clinical practise within our department.
An increased understanding of the aetiology of CF lung disease
confirms that even asymptomatic CF infants may have irreversible
pulmonary pathology. Consequently, early diagnosis and surveil-
lance of pulmonary disease is important for the preservation of
lung parenchyma and to optimise long term outcomes. Despite the
radiation doses incurred, CT is a vital imaging tool for CF patients,
demonstrating increased sensitivity compared with pulmonary
function tests and chest radiography.43,44 As such, there is an
ongoing onus to minimise radiation exposure, whilst maintaining
diagnostic quality images.
Secondary to the high inherent contrast and low radiation ab-
sorption of the lung, thoracic CT is particularly suited to dose
optimisation protocols. Low dose thin-section CT protocols for
paediatric CF patients can be conducted at a mean effective dose of
<0.02 mSv.45 In comparing protocols with section thickness of
0.5 mm and 1 mm, both demonstrate almost excellent diagnostic
acceptability and delineation of bronchovascular structures. Both
protocols also demonstrate excellent correlation with chest radio-
graph findings. Further published reports have confirmed an
effective dose reduction of 26% in this patient cohort following the
implementation of thin-section protocols, without any compromise
in image quality.46 Therefore, low dose thin-section CT, performed
at an effective dose approaching that of a chest radiograph, offers
an alternative, high-yield imaging option for paediatric CF patients.
Iterative reconstruction (IR) offers further potential for CT dose
optimisation in CF; when utilised with thoracic imaging in CF pa-
tients, IR facilitates contiguous/spiral chest imaging at chest radi-
ography doses. ASIR reconstructed thoracic CT images can remain
diagnostically satisfactory when obtained at 40 mAs/3.5 mGy.47
ASIR has also demonstrated potential in abdominal imaging
(Table 2). It can facilitate acquisition of diagnostically acceptable
low dose CT images of the urinary tract, at radiation dose exposures
approaching that of an abdominal radiograph.48 With a mean
effective dose of 0.48 mSv, low dose CT, reconstructed with 70%
ASIR, demonstrates a sensitivity and specificity of 87% and 100%,
respectively, for the detection of renal calculi >3 mm. Of note, the
fixed tube current low dose CT protocols demonstrate a reduction
in DLP with increasing patient BMI. This compares with the sta-
tistically significant increase in DLP noted when patients with
increasing BMI proceeded to conventional dose CT imaging.
Surveillance CT remains the standard of care following a diag-
nosis of testicular cancer; it is critical in the identification of
recurrent disease, such that it may be treated with curative intent.
Whilst surveillance recommendations vary between jurisdictions,
the majority of patients necessitate multiple abdominopelvic CT
examinations over the course of 5e10 follow-up years.49
MBIR has facilitated significant reductions in the radiation dose
associated with testicular cancer surveillance CT scans. Our centre
has demonstrated a radiation dose reduction of 67.1% with these
image reconstructions, whilst maintaining diagnostic accuracy.50 A
cohort of sixteen patients, with stage I or II testicular cancer, pro-
ceeded to low dose CTacquisition, subsequently reconstructedwith
MBIR; all images were comparable, if not superior, to conventional
dose imaging investigations in terms of quantitative image analysis.
All low dose images acquired demonstrated complete gold standard
correlation with the conventional dose CT images.
Additionally, MBIR has proven feasible as an option for the im-
aging of patients presenting with acute abdominal pain.51 In
demonstrating a 74.7% mean reduction in radiation dose, MBIR
offers a viable dose reduction strategy for this patient group. From a
cohort of fifty-seven patients, no difference in the sensitivity for
primary findings was recorded between the low dose images
Table 1
Effect of manipulation of scanning parameters on overall radiation dose exposure.
Scanning parameter Effect on radiation dose
Tube current Increased with higher tube current
Scan length Increased with lengthening of scan range
Pitch Decreased with higher pitch (at matched tube current)
Gantry rotation time Decreased with faster gantry rotation
Collimation Increased with thinner collimation
Distance of X-ray tube to CT isocenter Decreased with optimal patient centering
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reconstructed with MBIR and the standard dose images, barring a
single case of enteritis.
Compared with hybrid IR (combined filtered back projection
and ASIR), MBIR yields superior images in terms of subjective and
objective parameters for conventional dose CT enterography
studies.52 Of increased significance, for low dose CT enterography
reconstructed with MBIR, the acquired images are at least compa-
rable to, if not superior to, images resulting from conventional CT
protocols.53 These scans may be conducted with an average 74.7%
reduction in radiation dose exposure. Significantly, the detection of
complications of CD, in addition to an assessment of overall grade of
CD activity, are comparable when evaluated with both low dose
and conventional dose CT.
CT facilitates detailed detection of both intestinal and extra-
intestinal manifestations and complications of CD; it is frequently
conducted in the acute setting when there are clinical concerns
regarding extramural complications, including abscess and perfo-
ration. Although MRI and enterography provide superior contrast
resolution, and bowel wall and mucosal enhancement depiction,
MRI is not optimal for all patients with CD.
The advent of hybrid IR triggered the development of protocols
to guide low dose CT imaging of CD patients. CT-AP examinations
conducted for reconstruction with a combination of filtered back
projection and ASIR were noted to yield a mean effective dose of
1.3 mSv.54 This represented a 73.6% reduction in mean radiation
dose, compared with an effective dose of 4.7 mSv for conventional
CT-AP imaging. Furthermore, from a clinical perspective, detection
of extra-luminal complications was demonstrated to be compara-
ble between low dose and conventional dose abdominopelvic CT.
In more recent times, MBIR has proven of further benefit for CT-
AP dose reduction strategies in CD patients. In demonstrating
perfect clinical agreement with standard dose CT-AP for the
detection of extramural complications, low dose CT-AP protocols,
reconstructedwith pure IR, showpromise as an alternative imaging
option for the assessment of active CD.55
Low dose protocol inclusion into routine practise and future
developments
In view of cumulative radiation exposure, the frequent imaging
required in CF patients is a concern. Thoracic imaging typically
commences during infancy, as the earliest CF radiological changes,
mucous plugging, can be detected with CT imaging. Although CF is
a life limiting disease and therefore the risk of radiation induced
malignancy is reduced, life expectancy for CF patients continues to
improve.56 Median age of death from CF is rising, with an increase
of 0.543 life years per year across the US, England and Wales be-
tween 1972 and 2009. As such, there is an ongoing requirement,
supported by considerable academic and industry drive, to reduce
radiation exposure incurred by patients undergoing CT, without
sacrificing image quality and diagnostic accuracy.
Ireland has the highest worldwide incidence of CF57; prevalence
of the G551D mutation in patients at our CF centre is 23%.58 Iva-
caftor (Kalydeco; Vertex Pharmaceuticals, MA, USA) was the first
diseasemodifying drug in CF59; in Ireland, ivacaftor is nowavailable
for children from 1 year of age. Approved for use in CF patients with
the G551D mutation, ivacaftor improves lung function, reduces
sweat chloride levels and facilitates weight gain.60 We have pre-
viously reported improvements in the severity of CF lung disease,
using ultra-low dose CT (at a mean effective radiation dose of
Table 2
Overview of low dose CT imaging studies undertaken at our institution. The iterative reconstruction algorithms utilised for investigation of a particular pathology are pre-
sented. Subject age, DLP and ED are presented as means ± standard deviation. Dose reductions facilitated by these low dose CT protocols compared with conventional dose CT
studies are presented as ED or DLP as determined by published study data.
CT image reconstruction algorithm Pathology Subject age DLP ED Dose reduction
ASIR Renal calculi48 45.2 ± 16.3 years 34.18 ± 5.3 mGy.cm 0.48 ± 0.07 mSv 82.9 ± 8.0% (DLP)
ASIR CD (CT-AP)54 37 ± 13.4 years 87.0 ± 56.2 mGy.cm 1.26 ± 0.8 mSv 73.6 ± 2.6% (DLP)
MBIR Testicular cancer (CT-AP)50 35.6 ± 7.4 years 128 ± 38 mGy.cm 1.9 ± 0.6 mSv 67.1 ± 4.0% (DLP)
MBIR Acute abdomen51 56.5 ± 8 years 158.5 ± 118.6 mGy.cm 2.38 ± 1.78 mSv 74.7% (ED)
MBIR CD (CT enterography)52 38.5 ± 12.98 years 107.60 ± 78.7 mGy.cm 1.61 ± 1.18 mSv 74.7% (ED)
MBIR CD (CT-AP)55 37.8 ± 13.7 years 88 ± 58 mGy.cm 1.27 ± 0.87 mSv 71.4 ± 2.4% (DLP)
CD e Crohn's disease; CT-AP e abdominopelvic CT; DLP e dose length product; ED e effective dose.
Figure 1. Ultra-low dose CT images in a female CF patient, aged 22 years. Total ex-
amination dose length product of 5.75 mGy-cm. CT axial section a prior to
commencing treatment with ivacaftor (Kalydeco; Vertex Pharmaceuticals, MA, USA),
demonstrating right lower lobe cystic lung changes (arrow) and extensive left upper
lobe bronchial wall thickening (arrowhead); and b following six months of treatment
with ivacaftor, a dramatic improvement in the severity of both airway thickening and
cystic lung pathology is evident.
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0.08 mSv) for follow up imaging, post initiation of ivacaftor58
(Fig. 1).
All patients on treatment regimens with ivacaftor at our centre
proceed to ultra-low dose CT imaging (conducted at radiation dose
exposures approaching that of a standard chest radiograph) at
scheduled, routine intervals, in addition to clinical and respiratory
status assessments. The diagnostic acceptability of acquired ultra-
low dose CT images has frequently proven invaluable in clinical
practise. In cases of acute clinical deterioration, those recent CT
images obtained at baseline respiratory status can be compared
with newly acquired CT images, thus providing far superior
comparative detail of acute pathology than review of a prior chest
radiograph.
Employed for radiological follow up of CF patients, the volu-
metric low dose CT protocol is conducted with the following
parameters: tube voltage: 80 kV; tube current: 20 mA; gantry
rotation time: 0.4 s; pitch factor: 1.375; and FOV of 32 cm.
Scanning is performed at end-inspiration from the lung apices to
lung bases, to include the costophrenic recesses. Acquired at a
slice thickness of 0.625 mm, images are reconstructed at a final
slice thickness of 3 mm with MBIR in axial, coronal and sagittal
planes.
With children most susceptible to potential radiation induced
malignancy, the requirement to justify CT imaging and the need to
use the lowest radiation dose achievable has never been greater.
This is particularly relevant across the paediatric CF population,
due to early illness onset and an increased risk of high cumulative
radiation exposure throughout their lifelong illness. CT facilitates
demonstration of early CF changes, including mucous plugging
and bronchiectasis, at an earlier point than those abnormalities
detected by pulmonary function tests and chest radiography;
prompt diagnosis enables timely initiation of therapeutic in-
terventions. Additionally, both progression of CF pulmonary dis-
ease and any improvements following therapeutic interventions
can be accurately assessed with CT; timely adaptation of treat-
ment regimens assists with the ultimate aim of limiting disease
progression. As such, modified low dose CT protocols must be
considered for the paediatric CF cohort.61 An approval to adopt the
ultra-low dose CT protocol into routine practise for the imaging of
paediatric CF patients at our centre has recently been granted by
the local ethics board; formal results will be published in due
course.
Conclusion
Certain patient cohorts, namely those with CF and CD, essen-
tially require lifelong radiological follow-up. CT has an important
role in both disease surveillance and monitoring treatment
response. CT is also crucially important in the assessment of acute
flares of these disease states, presenting as an abrupt deterioration
in clinical status.
Consequently, control of cumulative radiation exposure is now
of utmost importance. Development and implementation of CT
dose reduction strategies and protocols is essential. In utilising the
lowest radiation dose possible, the beneficial effects of CT can be
maintained, whilst the potential for undesired ill effects are
minimised.
As outlined, a number of clinical conditions are suited to low
dose CT imaging protocols. In particular, low dose CT is an appro-
priate imaging option for accurate evaluation of pathological
changes in the CF lung, even at doses approaching that of a chest
radiograph. The diagnostic quality of these images has resulted in
successful implementation of the ultra-low dose protocols for
routine radiological follow up of CF patients.
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